Endogenous Peptide
C-Peptide Connects the Insulin Chains Before Processing
Connecting peptide has a defined role in insulin biosynthesis and a separate use as a circulating measurement. Proposed functions beyond those roles remain an active evidence question.
Educational content only. Not medical advice.
C-peptide is the connecting region of proinsulin
Within proinsulin, C-peptide connects the future insulin B and A chains and supports productive folding and disulfide formation. Secretory-granule enzymes cleave at paired basic sites and trim residues to release mature insulin and C-peptide. The C-peptide sequence is therefore encoded within INS but is not part of the two-chain mature insulin molecule. Proinsulin and partially processed intermediates remain distinct analytes.
Co-secretion does not mean identical concentration kinetics
Insulin and C-peptide are generated from the same processing event, but hepatic extraction and systemic clearance differ. Circulating measurements can therefore show different time courses and concentrations. Kidney function, sampling time, stimulation context, exogenous insulin exposure, and assay design affect interpretation. A C-peptide value is a biomarker measurement under defined conditions, not a complete description of beta-cell physiology by itself.
Assays must distinguish C-peptide from related precursors
Immunoassays depend on antibody specificity, calibration, matrix, interference, and cross-reactivity with proinsulin-related molecules. Reference methods and inter-laboratory standardization help, but results still require the assay and units. Pre-analytical handling and renal context matter. Combining C-peptide with glucose, insulin, proinsulin, timing, and the research question may improve interpretation, but this page does not interpret personal laboratory results.
Functional hypotheses should remain separate from biomarker use
C-peptide was historically treated mainly as a by-product, and studies have explored possible receptor-independent or signaling effects. Evidence varies by model and endpoint, and no single mechanism should be asserted without direct support. Its established value as a measured product of endogenous proinsulin processing does not automatically validate therapeutic claims. This article is limited to evidence literacy.
Evidence limits
- Assay calibration, cross-reactivity, kidney function, timing, and physiological context affect C-peptide measurements.
- Mechanistic studies do not automatically establish therapeutic effects.
- This page does not interpret an individual's laboratory value or recommend any use.
Sources and further reading
These sources ground the definitions and evidence boundaries on this page. A citation is a route for verification, not an endorsement of a product or personal use.
UniProt Consortium
INS - Insulin - Homo sapiens
Reviewed precursor entry identifying C-peptide, insulin chains, processing sites, and disulfide connectivity.
Open sourceNational Center for Biotechnology Information
INS Insulin Gene
Official human gene and RefSeq record for preproinsulin sequence and processing context.
Open sourceCommon questions
Is C-peptide part of mature insulin?
No. It connects the A and B regions in proinsulin and is removed during maturation.
Why can C-peptide and insulin levels differ?
They are co-secreted but have different hepatic extraction and clearance kinetics.
Can this page interpret a C-peptide blood test?
No. Personal results require assay, units, timing, clinical context, kidney function, and qualified interpretation.
Continue with context
Continue in the evidence workspace
Explore the complete PeptideSchool research workspace to organize sources, compare evidence layers, and follow related peptide science. Premium tools remain educational and do not provide individualized medical guidance.